tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMRN Stock Latest News

BioMarin Raises $850 Million Notes for Amicus Acquisition
Company AnnouncementsBioMarin Raises $850 Million Notes for Amicus Acquisition
4d ago
8K
BMRN
BioMarin price target lowered to $84 from $122 at Piper Sandler
PremiumThe Fly
BioMarin price target lowered to $84 from $122 at Piper Sandler
10d ago
BMRN
BioMarin Secures Major Debt Financing for Amicus Acquisition
PremiumCompany Announcements
BioMarin Secures Major Debt Financing for Amicus Acquisition
18d ago
8K
BMRN
BioMarin assumed with an Overweight at Barclays
PremiumThe Fly
BioMarin assumed with an Overweight at Barclays
20d ago
BMRN
BioMarin Announces Major Debt Financing for Amicus Acquisition
PremiumCompany Announcements
BioMarin Announces Major Debt Financing for Amicus Acquisition
21d ago
8K
BMRN
BioMarin upgraded to Buy from Hold at Canaccord
PremiumThe FlyBioMarin upgraded to Buy from Hold at Canaccord
27d ago
BMRN
FOLD
BioMarin: Undervalued Growth Story Reinforced by Strategic Amicus Acquisition and Expanding Rare-Disease Franchise
Premium
Ratings
BioMarin: Undervalued Growth Story Reinforced by Strategic Amicus Acquisition and Expanding Rare-Disease Franchise
27d ago
BMRN
BioMarin’s Palynziq Pregnancy Study: What the Latest Update Means for Investors
Premium
Company Announcements
BioMarin’s Palynziq Pregnancy Study: What the Latest Update Means for Investors
1M ago
BMRN
BioMarin Deepens Long-Term Palynziq Data With New PKU Post‑Marketing Study
PremiumCompany Announcements
BioMarin Deepens Long-Term Palynziq Data With New PKU Post‑Marketing Study
1M ago
BMRN
BioMarin’s PALace Study: Long-Term Safety Check on Palynziq and What It Means for Investors
PremiumCompany Announcements
BioMarin’s PALace Study: Long-Term Safety Check on Palynziq and What It Means for Investors
1M ago
BMRN
BioMarin: Sustained Double-Digit Growth Story Underpinned by Voxzogo Leadership, Advancing Rare-Disease Pipeline, and Accretive Amicus Acquisition
PremiumRatings
BioMarin: Sustained Double-Digit Growth Story Underpinned by Voxzogo Leadership, Advancing Rare-Disease Pipeline, and Accretive Amicus Acquisition
1M ago
BMRN
Balanced View on BioMarin: Solid Near-Term Guidance Offset by Voxzogo Competitive Risks and Roctavian Challenges, Supporting a Hold Rating
PremiumRatings
Balanced View on BioMarin: Solid Near-Term Guidance Offset by Voxzogo Competitive Risks and Roctavian Challenges, Supporting a Hold Rating
1M ago
BMRN
BioMarin: Buy Rating Reaffirmed on Strong 2025 Outlook, Promising Pipeline, and Accretive M&A
PremiumRatingsBioMarin: Buy Rating Reaffirmed on Strong 2025 Outlook, Promising Pipeline, and Accretive M&A
1M ago
BMRN
Closing Bell Movers: Revvity up 9% on strong outlook
Premium
The Fly
Closing Bell Movers: Revvity up 9% on strong outlook
1M ago
W
DAL
BioMarin sees FY25 revenue $3.2B, consensus $3.17B
Premium
The Fly
BioMarin sees FY25 revenue $3.2B, consensus $3.17B
1M ago
BMRN
BioMarin names Arpit Dave Chief Digital and Information Officer
PremiumThe Fly
BioMarin names Arpit Dave Chief Digital and Information Officer
1M ago
AMGN
BMRN
Veeva, BioMarin announce long-term enterprise agreement
PremiumThe Fly
Veeva, BioMarin announce long-term enterprise agreement
1M ago
BMRN
VEEV
BioMarin price target raised to $100 from $80 at Truist
PremiumThe Fly
BioMarin price target raised to $100 from $80 at Truist
2M ago
BMRN
FOLD
Spruce Biosciences initiated with an Outperform at Oppenheimer
PremiumThe Fly
Spruce Biosciences initiated with an Outperform at Oppenheimer
2M ago
BMRN
SPRB
BioMarin Ends Development of BMN 349 AATD Therapy
PremiumCompany AnnouncementsBioMarin Ends Development of BMN 349 AATD Therapy
2M ago
8K
BMRN
BofA moves to No Rating on Amicus after BioMarin deal
Premium
The Fly
BofA moves to No Rating on Amicus after BioMarin deal
2M ago
BMRN
FOLD
BioMarin price target raised to $60 from $55 at H.C. Wainwright
Premium
The Fly
BioMarin price target raised to $60 from $55 at H.C. Wainwright
2M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >